Contact Online Pharmacycheap Online PharmacyAbout Online Pharmacy

Anti Infective
Amoxicillin
Ceftin
Ciprofloxacin
Diflucan
Doryx
Doxycycline
Flumadine
Levaquin
Levofloxacin
Minocycline Penicillin VK Tamiflu Tetracycline Zithromax

Over-the-counter acquisition of antibiotics in the Maltese general population.

Few studies have studied the frequency of over-the-counter acquisition of antibiotics in western countries. In order to provide an insight into these practices in Malta, attitudes towards antibiotic use in the general public were researched through a structured interview. Nineteen percent admitted that they took antibiotics without prescription and 11% of parents replied that they had given antibiotics to their children without prescription. These antibiotics were mainly self-administered for upper respiratory tract symptoms, particularly sore throat, with community pharmacies being the major source in more than 85% of cases. The study indicates the need for an educational campaign on proper antibiotic use amongst the Maltese general public

Clostridium difficile infections related to antibiotic use and infection control facilities in two university hospitals.

We investigated whether a reduction in antibiotic use at the Aker University Hospital (Aker) led to a reduction in Clostridium difficile-associated diarrhoea (CDAD). We compared the incidence of CDAD in Aker and Tromsoe University Hospitals (Tromsoe) and related it to antibiotic use and facilities for infection control between 1993-2001. For this purpose we also performed point prevalence studies. Total antibiotic use was the same in the two hospitals. In spite of a reduction in the use of broad-spectrum antibiotics in Aker the incidence of CDAD increased during 1993-1999. In Tromsoe the use of broad-spectrum antibiotics and clindamycin was two to three times higher than in Aker, but until 1999 the incidence of CDAD remained constant and only half that of Aker. After 1999 the incidence of CDAD was halved in Aker, and increased three-fold in Tromsoe. Point prevalence studies in 2001 revealed an equal prevalence of antibiotic-associated diarrhoea. The facilities for infection control were better in Tromsoe. The percentage of single rooms were 8% in Aker and 14% in Tromsoe, and the percentage of single rooms with a WC was 6% in Aker and 12% in Tromsoe. The bed occupancy was much higher in Aker than in Tromsoe. Lack of facilities for infection control and higher bed occupancy could have contributed to the higher incidence of CDAD in Aker in spite of decreased use of broad-spectrum antibiotics and clindamycin. To limit CDAD in hospitals the focus must be on both rational antibiotic use and infection control

Prevention of antibiotic resistance needs informed parents

Antibiotic resistance is becoming worldwide a major challenge. Increasing rate of multidrug resistant bacteria is directly linked with the consumption of antibiotic. Children are the greatest consumers of antibiotics, but this large pediatric prescription is not justified, and responds, at least in part, to a "parental pressure". Therefore information to the parents about antibiotic is recommended. In order to promote this information the American Academy of Pediatrics recently wrote a booklet entitled "Your child and antibiotics" which is presented

Effects of antenatal antibiotics on the incidence and bacteriological profile of early-onset neonatal sepsis. A retrospective study over five years.

BACKGROUND: Recommendations for the use of antenatal antibiotics have been widely implemented in the past few years, notably to prevent group B streptococcal disease or to prolong pregnancy in the case of preterm premature rupture of the membranes. OBJECTIVES: We designed a retrospective study to assess the potential effects of this increasing use of antibiotics on the incidence and bacteriological profile of early-onset neonatal sepsis (EONS). METHODS: All neonates referred to our department for suspected EONS from January 1 1995 through December 31 1999 were included. Antenatal antibiotic exposure together with clinical and microbiological data from the neonatal period were gathered and analyzed on a yearly basis. RESULTS: Of the 485 newborns who met the inclusion criteria, there were 101 cases of culture-confirmed sepsis; 339 cases of suspected sepsis and 69 cases of confirmed sepsis involved children born in the hospital, among a total of 16,627 live births registered in our center over the study period. The overall incidence of EONS dropped from 6.8 to 0.6/1,000 births between 1995 and 1999 (p < 0.001), but the rate of group B streptococcal infection decreased much more rapidly than that of non-group B streptococcal infection. We observed a trend towards the emergence of ampicillin-resistant Escherichia coli strains, which were isolated in seven cases. Among E. COLI infections, ampicillin resistance was statistically linked with antenatal antibiotic use (p = 0.025). We also delineated several risk factors associated with these infections. CONCLUSION: In our center, antenatal antibiotic treatment was effective in reducing the incidence of EONS, but this benefit may come at the cost of favoring the emergence of ampicillin-resistant organisms causing severe neonatal infections. Antenatal and postnatal antibiotic treatment strategies should take this adverse effect into account.

The effect of rapid respiratory viral diagnostic testing on antibiotic use in a children's hospital.

BACKGROUND: Acute viral respiratory disease is the most common reason for pediatric hospitalization in the United States. Viral illnesses may be mistaken for bacterial infection, and antibiotic therapy may be prescribed. Overprescribing of antimicrobials for viral illness is a factor contributing to increasing antimicrobial resistance among bacterial pathogens encountered in pediatrics. OBJECTIVE: To determine if the availability of a rapid diagnostic test for respiratory viruses would affect antibiotic use in a children's hospital. DESIGN: Retrospective medical record review. SETTING: A 232-bed urban children's hospital. PARTICIPANTS: All hospitalized infants and children who underwent rapid testing (SimulFluor Respiratory Screen; Chemicon International Inc, Temecula, Calif) for respiratory viruses by direct fluorescent assay (DFA) during 2 successive winter seasons. MAIN OUTCOME MEASURES: Rates of antibiotic prescribing in DFA-positive and DFA-negative patients during the 2 study periods. RESULTS: During the first winter season, DFA-positive patients had fewer days using intravenous antibiotics (2.4 vs 4, P =.04), fewer days using oral antibiotics (0.25 vs 2.5, P =.04), and fewer discharge prescriptions for oral antibiotics (37% vs 52%, P =.02) when compared with DFA-negative patients. Intravenous antibiotics were initiated less often for DFA-positive patients during the second winter season than during the first (26% vs 44%, P =.008). CONCLUSIONS: Direct fluorescent assay testing was associated with a decrease in inappropriate antibiotic use. The availability of rapid viral diagnostics is an important tool for decreasing antibiotic prescribing in pediatric patients

Use of systemic antibiotics in a Norwegian nursing home

BACKGROUND: The population in the industrialised world is ageing; this brings an increase in the nursing home population. MATERIAL AND METHODS: In a 175-bed Norwegian nursing home a retrospective analysis was done by a manual search of all patient records for the year 1998, to establish the use of all systemic antibiotics that year. RESULTS: Out of 223 residents, 111 (50%) received 239 antibiotic treatments during the year. An average of 4.5% of the residents received antibiotics at any one time. Urinary tract infections accounted for 50% of antibiotics use followed by lower respiratory tract infections (27%) and skin and soft-tissue infections (11%). Trimethoprim and penicillin V accounted for 56% of the antibiotics used. INTERPRETATION: The choice of antibiotics was by and large in accordance with national guidelines for use of antibiotics in primary care. There is a need for further studies in order to develop consensus criteria for rational use of antibiotics in nursing homes

Infective Endocarditis.

Despite improvements in antibiotic regimens, patients with infective endocarditis (IE) have a high risk of valve replacement and death. Effective initial treatment depends on two steps: 1) diagnosis of the infecting organism, enabling specific antibiotic therapy, and 2) complete characterization of the anatomic extent of infection. Identification of the infecting organism requires culturing of blood prior to the initiation of antibiotics. Whenever possible, at least three sets of blood cultures should be obtained over 6 to 24 hours and held for 4 weeks if necessary to detect unusual or fastidious organisms. Transesophageal echocardiography (TEE) is usually necessary either to confirm the diagnosis or, most importantly, to identify the local complications of infection, many of which mandate surgery. Despite widespread availability, TEE remains under-used, both for the prevention of unnecessary antibiotic therapy in patients at very low risk for the disease and for the recognition of patients likely to benefit from early surgery. The selection of optimal antibiotic therapy depends on microbiologic data to establish the sensitivities of the specific causative organism. Short courses of antibiotic therapy and outpatient administration of intravenous antibiotics are useful in selected cases

Perinatal antibiotic usage and changes in colonization and resistance rates of group B streptococcus and other pathogens.

OBJECTIVE: To quantify current antibiotic usage during the perinatal period and impact on vaginal-rectal colonizing organism resistance rates. METHODS: Swabs were obtained for culture of group B streptococcus and other bacteria from a cohort of 1207 pregnant women in Calgary, Alberta, at 36 weeks' gestation. Those women who received antibiotics during labor or after pregnancy and a 10% subset who received no antibiotics had repeat cultures at 6 weeks postpartum. Cultured organisms were tested for sensitivity to several antibiotics. RESULTS: Group B streptococcus was identified in 235 women (19.5%) in the antepartum period. Fifty-one percent of all participants received antibiotics (31.4% intrapartum). Group B streptococcus prophylaxis was given to 215 (17.8%), whereas 83 (6.9%) group B streptococcus-negative women without fever during labor received antibiotics. Ampicillin (49%), cefazolin (28%), and penicillin (18%) were the most frequently used antibiotics. Resistance rates among group B streptococcus to erythromycin and clindamycin were 5.6% and 3.0%, respectively, whereas 20.6% of Escherichia coli were ampicillin resistant. Among antibiotic recipients, 6.3% of all bacteria that were initially sensitive on prenatal cultures to a specific antibiotic became resistant in the postnatal period, whereas 6.5% that were initially resistant became sensitive. CONCLUSION: Current prevention practices in our region were associated with perinatal antibiotic administration in over half of pregnant women. Ampicillin was the most common antibiotic administered. Some physicians are treating women who are group B streptococcus culture negative at term, a practice that is of no proven value. However, this was not associated with increased resistance for group B streptococcus or other organisms identified from maternal vaginal-rectal tracts

Ecological antibiotic policy.

Development of resistance to antibiotics is a major problem worldwide. The normal oropharyngeal flora, the intestinal flora and the skin flora play important roles in this development. Within a few days after the onset of antibiotic therapy, resistant Escherichia coli, Haemophilus influenzae and Staphylococcus epidermidis can be detected in the normal flora of volunteers or patients. Horizontal spread of the resistance genes to other species, e.g. Salmonella spp., Staphylococcus aureus and Streptococcus pneumoniae, occurs by conjugation or transformation. An ecologically sound antibiotic policy favours the use of antibiotics with little or no impact on the normal flora. Prodrug antibiotics which are not active against the bacteria in the mouth and the intestine (before absorption) and which are not excreted to a significant degree via the intestine, saliva or skin are therefore preferred. Prodrugs such as pivampicillin, bacampicillin, pivmecillinam and cefuroxime axetil are favourable from an ecological point of view. Experience from Scandinavia supports this, since resistance to mecillinam after 20 years of use is low (about 5%) and stable

Behavior of pythium Torulosum zoospores during their interaction with tobacco roots and Bacillus cereus.

Bacillus cereus UW85 suppresses seedling damping-off diseases caused by Oomycetes and produces antibiotics that inhibit development of Oomycetes in culture. The goal of this study was to determine how UW85 and its antibiotics affected the behavior of an Oomycete, Pythium torulosum, in its interaction with plant roots. We studied tobacco seedlings inoculated with zoospores of P. torulosum and UW85 culture, culture filtrate, washed cells, antibiotics (zwittermicin A or kanosamine), purified from cultures of UW85, and UW030, a mutant of UW85 that does not suppress disease and does not produce the antibiotics. Microscopic observation revealed that all of the treatments inhibited zoospore activity around roots and encystment on roots. Treatment with UW85 culture, culture filtrate, zwittermicin A, or kanosamine delayed cyst germination and the elongation rate of germ tubes, whereas treatment with UW030 or washed UW85 cells did not. In an in vitro seedling bioassay of disease suppression, the antibiotics, zwittermicin A and kanosamine, suppressed disease singly or together, although UW85 culture suppressed disease more effectively than did the antibiotics. The results show that B. cereus cultures affect zoospore behavior in the presence of roots, and B. cereus-produced antibiotics, zwittermicin A and kanosamine, contribute to disease suppression and inhibition of germ tube elongation in the presence of the plant root

 

antibiotic antiviral antibiotics antiviral 1 | antibiotic antiviral antibiotics antiviral 2 | antibiotic antiviral antibiotics antiviral 3 | antibiotic antiviral antibiotics antiviral 4 | antibiotic antiviral antibiotics antiviral 5 | antibiotic antiviral antibiotics antiviral 6 | antibiotic antiviral antibiotics antiviral 7 | antibiotic antiviral antibiotics antiviral 8 | antibiotic antiviral antibiotics antiviral 9 | antibiotic antiviral antibiotics antiviral 10 | antibiotic antiviral antibiotics antiviral 11 | antibiotic antiviral antibiotics antiviral 12 | antibiotic antiviral antibiotics antiviral 13 | antibiotic antiviral antibiotics antiviral 14 | antibiotic antiviral antibiotics antiviral 15 | antibiotic antiviral antibiotics antiviral 16 | antibiotic antiviral antibiotics antiviral 17 | antibiotic antiviral antibiotics antiviral 18 | antibiotic antiviral antibiotics antiviral 19 | antibiotic antiviral antibiotics antiviral 20 | antibiotic antiviral antibiotics antiviral 21 | antibiotic antiviral antibiotics antiviral 22 | antibiotic antiviral antibiotics antiviral 23 | antibiotic antiviral antibiotics antiviral 24 | antibiotic antiviral antibiotics antiviral 25 | antibiotic antiviral antibiotics antiviral 26 | antibiotic antiviral antibiotics antiviral 27 | antibiotic antiviral antibiotics antiviral 28 | antibiotic antiviral antibiotics antiviral 29 | antibiotic antiviral antibiotics antiviral 30 | antibiotic antiviral antibiotics antiviral 31 | antibiotic antiviral antibiotics antiviral 32 | antibiotic antiviral antibiotics antiviral 33 | antibiotic antiviral antibiotics antiviral 34 | antibiotic antiviral antibiotics antiviral 35 | antibiotic antiviral antibiotics antiviral 36 | antibiotic antiviral antibiotics antiviral 37 | antibiotic antiviral antibiotics antiviral 38 | antibiotic antiviral antibiotics antiviral 39 | antibiotic antiviral antibiotics antiviral 40 | antibiotic antiviral antibiotics antiviral 41 | antibiotic antiviral antibiotics antiviral 42 | antibiotic antiviral antibiotics antiviral 43 | antibiotic antiviral antibiotics antiviral 44 | antibiotic antiviral antibiotics antiviral 45 | antibiotic antiviral antibiotics antiviral 46 | antibiotic antiviral antibiotics antiviral 47 | antibiotic antiviral antibiotics antiviral 48 | antibiotic antiviral antibiotics antiviral 49 | antibiotic antiviral antibiotics antiviral 50 |
Secure Online Ordering FedEx Shipping